FDA Inspection
Carter BloodCareCarter BloodCare – FDA Inspection, Oct 15, 2010
Record Details
This FDA Inspection record concerns Carter BloodCare, with an inspection on October 15, 2010, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Carter BloodCare
- Inspection Date
- October 15, 2010
- Product Type
- Biologics
View Company Profile
ID · e18eef6b-cfc5-484e-b35c-19171bc083b0
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 694671
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 640.21(a)Eligibility of platelet donors
- 21 CFR 606.100(c)Thorough investigations
- 21 CFR 606.65(e)Following manufacturer"s instructions
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Carter BloodCare
6| Date | Classification | Office | Project area |
|---|---|---|---|
| June 24, 2026 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 9, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 26, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 12, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| November 16, 2012 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Carter BloodCare
- FDA Inspection 1325168 - 2026-06-24
- FDA Inspection 1100120 - 2019-08-09
- FDA Inspection 1023643 - 2017-07-26
- FDA Inspection 931289 - 2015-06-12
- FDA Inspection 808008 - 2012-11-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.